5.2
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
View/Download PDF

Translate this page into:

Original article
10 (
2_suppl
); S2890-S2895
doi:
10.1016/j.arabjc.2013.11.018

Green synthesis, characterization and biological evaluation of novel chalcones as anti bacterial agents

Chemistry Department, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia
Center of Excellence for Advanced Materials Research, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia

⁎Corresponding author. Tel.: +966 568966770. sahmad_phd@yahoo.co.in (Salman A. Khan)

Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.

Peer review under responsibility of King Saud University.

Abstract

Chalcone derivatives have been synthesized by the reaction of 3-acetyl-2,5-dimethylthiophene with corresponding active aldehyde in ethanolic NaOH in microwave oven. The structure of these compounds was established by elemental analysis, IR, 1H NMR, 13C NMR and EI-MS spectral analysis. The anti-bacterial activity of these compounds were first tested in vitro by the disk diffusion assay against two Gram-positive and two Gram-negative bacteria, and then the minimum inhibitory concentration (MIC) was determined with the reference of standard drug Chloramphenicol. The results showed that compound 8 is a better inhibitor of both types of the bacteria (Gram-positive and Gram-negative) as compared to chloramphenicol.

Keywords

Chalcones
Anti-bacterial activity
Chloramphenicol
1

1 Introduction

Bacterial infections are the serious health problems in various developing countries, Asian sub-continent, some parts of South America, tropical parts of Africa and Middle East (Lopez et al., 2011; Arbolave et al., 2006). Food poisoning, rheumatic, salmonellosis and diarrhea are caused by multidrug-resistant Gram-positive and Gram-negative pathogens such as Staphylococcus aureus, Staphylococcus pyogenes, Salmonella typhimurium and Escherichia coli (Khan 2008; Khan and Asiri, 2012). Millions of people in the subtropical regions of the world are infected and 20,000 died every year due to these parasitic bacterial infections (Datta et al., 1974). Amoxicillin, norfloxacin, and ciprofloxacin are the principal drugs of choice in the treatment of bacterial infection since they are effective against extraintestinal and intestinal wall infection, but these are associated with several side effects such as nausea, metallic taste, dizziness, hypertension, etc. and resistance has been reported (Bhattachary and Sen 1965; Khan et al., 2013a,b). The present strategy for new drug development acts as an antibacterial agent. The study of chalcone derivatives has become of much interest in recent years on account of their antibacterial, antiviral, anti-cancer, anti-fungal, anti-helmithic and insecticidal activities (Prasad et al., 2008; Sharma et al., 2011; Anto et al., 1995; Nerya et al., 2004; Khan et al., 2013b). Heterocyclic ring containing chalcones dramatically increase the diversity of certain biological properties such as antibacterial, antiviral and antiamoebic activities (Asiri and Khan, 2011a,b, 2012). Various synthetic methods have been reported so far, such as refluxing in an organic solvent (Hayat et al., 2011), the solvent-free solid-phase reaction (Asiri and Khan, 2011b), ultrasonication (Jayapal and Sreedhar 2010) and microwave radiation (Calvino et al., 2006). In this paper we synthesized the calcone derivatives by microwave radiation as antibacterial agent.

2

2 Experimental

2.1

2.1 General method for the synthesis of chalcones

To a solution of 3-acetyl-2,5-dimethylthiophene (0.38 g, 0.0025 mol) and the corresponding active aldehyde (0.0025 mol) in dry ethanol (20 ml) taken in a beaker (100 ml), a catalytic quantity of sodium hydroxide (0.05 g, 1.25 mmol) was added and the reaction mixture was heated inside a microwave oven for 30–50 s. (at 210 W, i.e. 30% microwave power) (Asiri et al., 2013). The reactions were monitored through TLC using solvent system ethyl acetate:benzene (2:8), when the reaction was found to be complete, the reaction mixture was cooled in an ice bath and the product thus formed was filtered, washed with ethanol followed by washing with water till the washings were neutral and recrystallized by distilled ethanol and chloroform.

2.1.1

2.1.1 (E)-1-(2,5-dimethyl-3-thienyl)-3-(2-hydroxyphenyl)prop-2-en-1-one (1)

Light-yellow solid: m.p 146–147 °C; EI-MS m/z (rel. int.%): 260 (65) [M+1]+. IR (KBr) vmax cm−1: 3414 (OH), 2911 (C—H), 1652 (C⚌O), 1572 (C⚌C); 1H NMR (600 MHz, DMSO-d6) (δ/ppm): 8.61 (s, OH), 8.16 (d, C⚌CH, J = 15.6 Hz), 7.62 (s, CH, 7.45 (d, CH⚌C, J = 15.6 Hz), 7.56 (d, CH, J = 7.2 Hz), 7.15 (dd, CH, J = 7.8, 7.8 Hz), 6.97 (dd, CH, J = 8.4, 7.2 Hz), 2.73 (s, CH3), 2.43 (s, CH3); 13C NMR (CDCl3) δ: 188.11, 156.11, 148.81, 147.45, 140.15, 136.70, 131.81, 125.01, 122.25, 120.10, 118.47, 116.63, 48.05, 16.25, 14.98; Anal. calcd. for C15H14O2S: C, 69.74, H, 5.46, S, 12.41. Found: C, 69.71, H, 5.42, S, 12.38.

2.1.2

2.1.2 (2E)-1-(2,5-dimethyl-3-thienyl)-3-(2-methoxyphenyl)prop-2-en-1-one (2)

Light-yellow solid: m.p 91–92 °C; EI-MS m/z (rel. int.%): 274 (60) [M+1]+. IR (KBr) vmax cm−1: 2923 (C—H), 1653 (C⚌O), 1596 (C⚌C); 1H NMR (600 MHz, DMSO-d6) (δ/ppm): 8.10 (d, C⚌CH, J = 15.6 Hz), 7.52 (d, CH, J = 7.8 Hz), 7.45 (d, C⚌CH, J = 15.6 Hz), 7.44 (s, CH, 7.24 (dd, CH, J = 1.2, 1.2 Hz), 7.07 (s, CH), 7.00 (d, CH, J = 7.8 Hz), 6.90 (dd, CH, J = 7.2, 7.2 Hz), 2.73 (s, CH3), 2.43 (s, CH3); 13C NMR (CDCl3) δ: 187.94, 156.32, 147.36, 140.19, 139.71, 134.69, 131.64, 129.13, 126.20, 125.00, 122.15, 120.36, 116.73, 58.53, 16.32, 14.98, Anal. calcd. for C16H16O2S: C, 70.56, H, 5.92, S, 11.77. Found: C, 70.52, H, 5.88, S, 11.73.

2.1.3

2.1.3 (2E)-3-(3,4-dimethoxyphenyl)-1-(2,5-dimethylthiophen-3-yl)prop-2-en-1-one (3)

Light-yellow solid: m.p 114–115 °C; EI-MS m/z (rel. int.%): 304 (72) [M+1]+. IR (KBr) vmax cm−1: 2909 (C—H), 1647 (C⚌O), 1583 (C⚌C); 1H NMR (600 MHz, DMSO-d6) (δ/ppm): 7.66 (d, C⚌CH, J = 15.6 Hz), 7.27 (s, CH), 7.20 (d, CH, J = 8.4 Hz), 7.14 (d, CH⚌C, J = 15.6 Hz), 6.89 (d, CO⚌CH, J = 8.4 Hz), 6.89 (s, CH), 3.97 (OCH3), 3.89 (OCH3), 2.69 (s, CH3), 2.44 (s, CH3); 13C NMR (CDCl3) δ: 151.12, 149.09, 146.79, 143.76, 136.78, 135.12, 127.88, 125.91, 122.95, 122.90, 110.97, 109.82, 77.28, 55.96, 55.91, 15.82, 15.06; Anal. calcd. for C17H18O3S: C, 67.52, H, 6.00, S, 10.60. Found: C, 67.48, H, 5.98, S, 10.56.

2.1.4

2.1.4 1-(2,5-Dimethyl-3-thienyl)-3-(2,4,5-trimethoxyphenyl)prop-2-en-1-one (4)

Light-yellow solid: m.p. 107–108 °C; EI-MS m/z (rel. int.%): 334 (61) [M+1]+. IR (KBr) vmax cm−1: 3016 (Ar–H), 2924 (C—H), 1642 (C⚌O), 1572(C⚌C); 1H NMR (600 MHz, CDCl3)(δ/ppm): 8.01 (d, C⚌CH, J = 15.6 Hz), 7.26 (s, 1H, CHaromatic), 7.20 (d, CO⚌CH, J = 15.6 Hz), 7.08 (s, CHaromatic), 6.51 (s, 1H, 4-CH thiophene), 3.94 (s, OCH3), 3.73 (s, OCH3), 3.62 (s, OCH3), 2.44 (s, 3H, CH3), 2.17 (s, 3H, CH3); 13C NMR (CDCl3) δ: 187.22, 154.44, 152.18, 146.21, 143.11, 138.89, 137.16, 135.08, 126.06, 123.10, 115.45, 111.06, 96.70, 56.49, 56.35, 56.04, 15.80, 15.08; Anal. calcd. for C18H20SO4: C, 65.04, H, 6.06. Found: C, 64.98, H, 5.97.

2.1.5

2.1.5 3(4-Dimethylamino-phenyl)-1-(2,5-dimethyl-thiophen-3-yl)-propenone (5)

Yellow solid: m.p. 102–103 °C; EI-MS m/z (rel. int.%): 287 (60) [M+1]; IR (KBr) vmax cm−1: 2979 (C—H,aliphatic), 1638 (C⚌O), 1612 (C⚌C), 1167 (C-N). 1H NMR (DMSO-d6) (δ/ppm): 7.68 (d, 2H, J = 15.6 Hz, C⚌CH), 7.08 (d, 2H, J = 15.6 Hz, CO⚌CH), 7.51 (d, CH, J = 9.0 Hz), 6.68 (d, CH, J = 9 Hz), 7.25 (s, 1H, thiophene-H), 3.02 (s, N-CH3), 2.68 (s, CH3), 2.43 (s, CH3); 13C NMR (DMSO-d6) (δ/ppm): 186.97, 151.81, 145.59, 137.35, 135.80, 130.19, 125.07, 122.62, 119.92, 111.75, 40.13, 15.74, 15.06; Anal. calcd. for C17H19NOS: C, 71.54, H, 6.71, N, 4.91, S, 11.23. Found: C, 71.48, H, 6.68, N, 4.88, S, 11.18

2.1.6

2.1.6 (2,5-Dimethyl-thiophen-3-yl)3-(9-ethyl-(9H-carbazol-3-yl)-propenone (6)

Yellow solid: m.p. 119 °C; EI-MS m/z (rel. int.%): 362 (65) [M+1]+. IR (KBr) vmax cm−1: 3047 (C—H), 2912 (C—H, aliphatic), 1636 (C⚌O), 1639 (C⚌C), 1124 (C-N). 1H NMR (DMSO-d6) (δ/ppm): 8.62 (d, CH, J = 1.2 Hz), 8.34 (d, CH, J = 1.2 Hz), 8.15 (d, CH, J = 7.8 Hz), 7.76, (dd, CH, J = 1.2), 7.52 (dd, CH, J = 1.2 Hz), 7.95 (d, C⚌CH, J = 15.6 Hz), 7.33 (d, 2H, J = 15.6 Hz, CO⚌CH), 7.26 (s, 1H, CH thiophene), 7.44 (s, CH), 4.42 (t N-CH2-CH3, J = 7.2 Hz), 1.48 (q, N-CH2-CH3, J = 7.2 Hz), 2.47 (s, CH3), 2.11 (s, CH3) 13C NMR (DMSO-d6) (δ/ppm): 191.33, 186.30, 146.41, 145.26, 140.42, 137.13, 137.18, 126.72, 126.23, 125.97, 123.40, 122.32, 121.43, 120.31, 119.62, 108.37, 37.93, 37.77, 15.34, 15.10, 13.35, 13.33. Anal. calcd. for C23H21NOS: C, 76.85, H, 5.89, N, 3.90, S, 8.92. Found: C, 76.82, H, 5.85, N, 3.86, S, 8.87.

2.1.7

2.1.7 (2E)-1-(2,5-dimethyl-3-thienyl)-3-(4-nitrophenyl)propenone (7)

Light-yellow solid: m.p. 130–131 °C; EI-MS m/z (rel. int.%): 289 (62) [M+1]+. IR (KBr) v cm−1: 3012 (Ar–H), 2926 (C—H), 1628 (C⚌O), 1568 (C⚌C); 1H NMR (600 MHz, CDCl3) (δ/ppm): 8.47 (d, J = 1.8 Hz), 8.23 (d, J = 1.2 Hz), 7.73 (d, C⚌CH, J = 15.6 Hz), 7.40 (d, CO⚌CH, J = 15.6 Hz), 7.89 (d, J = 7.2 Hz), 7.61 (d, J = 7.8 Hz), 7.27 (s, Ar–H), 2.72 (s, CH3), 2.39 (s, CH3); 13C NMR (CDCl3) δ: 185.23, 148.66, 148.62, 140.32, 136.79, 136.01, 135.68, 134.31, 129.98, 127.45, 125.76, 124.43, 122.16, 16.06, 15.05; Anal. calcd. for C15H13NO3S: C, 62.70, H, 4.56, N, 4.87. Found: C, 62.66, H, 4.52, N, 4.83.

2.1.8

2.1.8 (2E)-3-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)-1-(2,5-dimethyl-3-thienyl)prop-2-en-1-one (8)

Light-yellow solid: m.p. 111–112 °C; EI-MS m/z (rel. int.%): 337 (65) [M+1]+. IR (KBr) vmax cm–1: 3055 (Ar–H), 2918 (C—H), 1642 (C⚌O), 1575 (C⚌C); 1H NMR (DMSO-d6) (δ/ppm): 7.71 (d, C⚌CH, J = 16.2 Hz,), 7.35 (d, CO⚌CH, J = 16.0 Hz), 7.19(s, 1H, thiophene), 7.24–6.93 (m, 5H, Ph), 2.65 (s, 3H, pyrazole 3-CH3), 2.44 (s, 3H, pyrazole 5-CH3), 2.37 (s, 3H, thiophene 2-CH3), 2.36 (s, 3H, thiophene 5-CH3). 13C NMR (CDCl3) δ: 185.43 (CO), 150.79 (10-C), 145.59, 140.04, 137.90, 136.00, 134.25, 133.86, 128.32, 127.74, 124.82, 123.89, 117.92, 114.32, 28.67, 14.92, 13.94, 11.96, 10.62; Anal. calcd. for C20H20N2OS: C, 71.40, H, 5.99, N, 8.33. Found: C, 71.36, H, 5.95, N, 8.28.

2.2

2.2 Organism culture and in vitro screening

Antibacterial activity was examined by the disk diffusion method with minor modifications. S. aureus, S. pyogenes, S. typhimurium and E. coli were sub-cultured in BHI medium and incubated for 18 h at 37 °C, and then the bacterial cells were suspended, according to the McFarland protocol in saline solution to produce a suspension of about 10−5 CFU mL−1:10 μL of this suspension was mixed with 10 mL of sterile antibiotic agar at 40 °C and poured onto an agar plate in a laminar flow cabinet. Five paper disks (6.0 mm diameter) were fixed onto nutrient agar plate. 1 mg of each test compound was dissolved in 100 μL of DMSO to prepare stock solution and from the stock solution different concentrations 10, 20, 25, 50, and 100 μg/μL of each test compound were prepared. These compounds of different concentration were poured onto disk plate. Chloramphenicol (30 μg/disk) was used as standard drug (positive control). DMSO poured disk was used as negative control. The susceptibility of the bacteria to the test compounds was determined by the formation of an inhibitory zone after 18 h of incubation at 36 °C. (Table 1) reports the inhibition zones (mm) of each compound and the controls. The minimum inhibitory concentration (MIC) was evaluated by the macro dilution test using standard inoculums of 10−5 CFL mL−1. Serial dilutions of the test compounds, previously dissolved in dimethyl sulfoxide (DMSO) were prepared to final concentrations of 512, 256, 128, 64, 32, 16, 8, 4, 2 and 1 μg/mL and to each tube was added 100μL of a 24 h old inoculum. The MIC, defined as the lowest concentration of the test compound, which inhibits the visible growth after 18 h, was determined visually after incubation for 18 h, at 37 °C, and the results are presented in Table 2. Tests were performed using DMSO and chloramphenicol as negative and positive controls.

Table 1 Physicochemical data of the synthesized compounds (18).
Compound No. Molecular formula Crystallization % Yield Reaction Time (micro wave)
1 C15H14O2S CHCl3 88.2 30 s
2 C16H16O2S CH2Cl2 88.5 45 s
3 C17H18O3S CH2Cl2 82.0 43 s
4 C18H20O4S CHCl3 88.0 50 s
5 C17H19NOS CHCl3 86.00 35 s
6 C23H21NOS CH2Cl2 90.0 42 s
7 C15H13NO3S CHCl3 89.2 38 s
8 C20H20N2OS CHCl3 89.6 45 s
Table 2 Antibacterial activity of chalcones, positive control chloramphenicol (Chlora.) and negative control DMSO measured by the Halo Zone Test (Unit, mm).
Compounds Corresponding effect on microorganisms
S. aureus S. pyogenes S. typhimurium E. coli
1 10.1 ± 0.3 9.8 ± 0.2 9.2 ± 0.3 10.3 ± 0.4
2 11.3 ± 0.2 11.6 ± 0.3 10.4 ± 0.4 12.2 ± 0.3
3 9.8 ± 0.3 10.5 ± 0.4 10.8 ± 0.2 11.2 ± 0.5
4 9.6 ± 0.4 9.2 ± 0.4 11.9 ± 0.4 12.2 ± 0.1
5 10.4 ± 0.2 11.8 ± 0.3 11.5 ± 0.4 12.5 ± 0.4
6 11.2 ± 0.4 10.7 ± 0.4 12.6 ± 0.5 12.8 ± 0.5
7 11.4 ± 0.3 12.4 ± 0.5 12.8 ± 0.2 13.4 ± 0.5
8 18.2 ± 0.4 18.8 ± 0.5 20.8 ± 0.4 22.4 ± 0.5
Chlora. 17.0 ± 0.5 18.2 ± 0.4 17.2 ± 0.8 20.0 ± 0.2
DMSO

3

3 Results and discussion

3.1

3.1 Synthesis and characterization

Chalcone derivatives were synthesized by the reaction of 3-acetyl-2,5-dimethylthiophene and the corresponding active aldehyde (Scheme 1 and Table 1). The purified products were characterized by EI-MS m/z (rel. int.%): FT-IR, 1H NMR, 13C NMR and elemental analysis. The IR spectra of compounds (18) show the characteristic band. The ν(C⚌O) peak of Act-thiophen observed at 1668 cm−1 shifts to a lower frequency of 1628–1653 cm−1 of chacones. This is due to the conjugation of the π-electrons on the benzene moiety with those on the ethylene moiety in the enon linkage. 1H NMR spectra, is a proven diagnostic tool for the positional elucidation of the proton. Assignments of the signals are based on chemical shift and intensity pattern. The 1H NMR spectra of all the compounds (1–8) measured at room temperature shows two doublets at 7.68–8.16 ppm (J = 15.6) for the CH⚌C and 6.89–7.45 ppm (J = 15.6 Hz) for the CO⚌CH indicating that the ethylene moiety in the enon linkage is in the trans-conformation which conform the formation of chalcones.

Synthetic route of the chalcones (1–8).
Scheme 1 Synthetic route of the chalcones (1–8).

13C NMR (CDCl3) spectra of chalcones (1–8) were recorded in CDCl3 and spectral signals are in good agreement with the probable structures details of 13C NMR spectra of all compounds and those data are given in the experimental section.

Characteristic peaks were observed in the EI mass spectra of compounds (18), which followed the molecular ion peak and similar fragmentation pattern.

3.2

3.2 Antimicrobial activity: disc-diffusion and micro dilution assay

The compounds (18) were tested for their antibacterial activities by disc-diffusion method using nutrient broth medium [contained (g/L): beef extract 3 g; peptone 5 g; pH 7.0] (Asiri and Khan 2010). The Gram-positive bacteria and Gram-negative bacteria utilized in this study consisted of S. aureus, S. pyogenes, S. typhimurium and E. coli. In the disc-diffusion method, sterile paper disks (0.5 mm) impregnated with compound dissolved in dimethylsulfoxide (DMSO) at concentration of 100 μg/mL were used. Then, the paper disks impregnated with the solution of the compound tested were placed on the surface of the media inoculated with the microorganism. The plates were incubated at 35 °C for 24 h. The growth inhibition zones after incubation are shown in Table 2. The chalcone derivative was further checked by the MIC method. The results are presented in Table 3.

Table 3 Minimum inhibition concentration (MIC) of chalcone (1–8) products, positive control: chloramphenicol.
Bacterial strain MIC (μg mL−1) compound Positive
1 2 3 4 5 6 7 8 Control
S. aureus 256 128 512 512 256 128 128 32 32
S. pyogenes 512 128 256 512 128 128 64 32 32
S. typhimurium 512 256 256 128 128 64 64 16 32
E. coli 256 128 256 128 128 64 64 16 32

4

4 Conclusion

A chalcone was prepared by the reaction of 3-acetyl-2,5-dimethylthiophene with the corresponding active aldehyde in ethanolic NaOH in microwave oven. The antibacterial activity of these compounds was examined using culture of bacteria and the results showed that the nitrogen containing chalcone increased the antibacterial activity. Among the entire eight compounds, pyrazol containing chalcone (8) showed better antibacterial activity on S. sureus and S. pyogenes than the reference drug chloramphenicol.

Acknowledgements

Authors are thankful to the Center of Excellence for Advanced Materials Research and the Chemistry Department at King Abdulaziz University for providing the research facilities.

References

  1. , , , , , , . Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett.. 1995;97:33-37.
    [Google Scholar]
  2. , , , , . Aspectos clinico-epidemiologicos de la infection por virus de la gripe A en menores de 7 anos atencion primaria. Anales de Pediatria.. 2006;65:211-218.
    [Google Scholar]
  3. , , . Synthesis, anti-bacterial activities of some novel Schiff bases derived from amino phenazone. Molecules. 2010;15(10):6850-6858.
    [Google Scholar]
  4. , , . Synthesis and Anti-Bacterial Activities of a Bis-Chalcone Derived from Thiophene and Its Bis-Cyclized Products. Molecules. 2011;16:523-531.
    [Google Scholar]
  5. , , . Synthesis, characterization and optical properties of mono- and bis-chalcone. Material Lett.. 2011;65:1749-1752.
    [Google Scholar]
  6. , , . Synthesis, Characterization, and In Vitro Antibacterial Activities of Macromolecules Derived from Bis-Chalcon. J. Hetrocycl. Chem.. 2012;49:1434-1438.
    [Google Scholar]
  7. , , , , . Synthesis, spectroscopic and physicochemical investigation of environmentally benign heterocyclic Schiff base derivatives as antibacterial agents on the bases of in vitro and density functional theory. J. Phtochem. Photobiol. B. 2013;120:82-89.
    [Google Scholar]
  8. , , . Chemotherapeutic properties of some new quaternary ammonium compounds; their cesticidal action against hymenolepis nana. Br. J. Pharmacol. Chemother.. 1965;24:240-244.
    [Google Scholar]
  9. , , , , , . Ultrasound accelerated Claisen–Schmidt condensation: A green route to chalcones. Appl. Surface Sci.. 2006;252:6071-6607.
    [Google Scholar]
  10. , , , . Treatment of amebic liver abscess with emetine hydrochloride, niridazole, and metronidazole: a controlled clinical trial. Am. J. Trop. Med. Hyg.. 1974;23:586-589.
    [Google Scholar]
  11. , , , , , . Antiprotozoal activity of chloroquinoline based chalcones. Eur. J. Med. Chem.. 2011;46:1897-1905.
    [Google Scholar]
  12. , , . Anhydrous K2CO3 as Catalyst for the synthesis of Chalcones under Microwave Irradiation. J. Pharm. Sci. Res.. 2010;2:644-647.
    [Google Scholar]
  13. , . Synthesis, characterization and in vitro antibacterial activity of new steroidal 5-en-3-oxazolo and thiazoloquinoxaline. Eur. J. Med. Chem.. 2008;43:2040-2044.
    [Google Scholar]
  14. , , . Synthesis and in vitro antibacterial activity of novel steroidal (6r)-spiro-1,3,4-thiadiazoline derivatives. J. Heterocyclic Chem.. 2012;49:1452-1457.
    [Google Scholar]
  15. , , , , , . Eco-friendly synthesis and in vitro antibacterial activities of some novel chalcones. Russ. J. Bioorg. Chem.. 2013;39:353-357.
    [Google Scholar]
  16. , , , . Synthesis of steroidal thiazolidinones as antibacterial agents based on the in-vitro and quantum chemistry calculation. Med. Chem. Res.. 2013;22:1998-2004.
    [Google Scholar]
  17. , , , , , , , , , . Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicentertrial. Clinical Therapeutics.. 2011;25:1846-1871.
    [Google Scholar]
  18. , , , , , . Chalcones as potent tyrosinase inhibitors: the effect of hydroxyl positions and numbers. Phytochemistry. 2004;65:1389-1395.
    [Google Scholar]
  19. , , , , . QSAR studies on chalcone derivatives as antibacterial agents against Bacillus pumilis. Eur. J. Med. Chem.. 2008;43:2220-2228.
    [Google Scholar]
  20. , , , , , , . Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors. Bioorg. Med. Chem.. 2011;19:2030-2045.
    [Google Scholar]
Show Sections